Alternatives to Mondae

Four flat, posted price points across semaglutide and three tirzepatide formats, with a written promise the cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.

• $16/mo cheaper than Mondae
• has an oral option if you would rather not inject
• scores 75/100 against Mondae's 46

Shapely is the first provider in this batch that takes insurance — it says it is in network with Medicare and major PPO plans, and quotes brand-name co-pays of "typically $25 per month". That genuinely changes the arithmetic for anyone with coverage. What has to be read carefully is what the membership buys: $99 a month, $49 for the first, and it explicitly does not include medications or labs. So the compounded prices, $99 for semaglutide and $166 for tirzepatide, sit on top of the membership rather than replacing it.

• $16/mo cheaper than Mondae
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

A low-entry, all-in compounded program with both molecules and a clean cancel-anytime policy — appealing if the starting price holds, but the ongoing rate isn't published and the outcome claims are unverified marketing.

• $16/mo cheaper than Mondae
• scores 76/100 against Mondae's 46

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

• $16/mo cheaper than Mondae
• has an oral option if you would rather not inject
• scores 58/100 against Mondae's 46

Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

• has an oral option if you would rather not inject
• scores 80/100 against Mondae's 46

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject
• scores 76/100 against Mondae's 46

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject
• scores 76/100 against Mondae's 46

A rare needle-free option at true price parity — $79/mo semaglutide or $133/mo tirzepatide, injectable or oral, same price — though NuuVim frames it as a new-patient rate with an unpublished refill tier, and its 50-state coverage claim couldn't be confirmed on its own live site this pass.

• $36/mo cheaper than Mondae
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

A LegitScript-certified compounded GLP-1 platform advertising $89/mo semaglutide and $139/mo tirzepatide — but those are first-month-only promos, the real month-two price is never published, and nothing addresses PCOS, postpartum, or breastfeeding.

• $26/mo cheaper than Mondae
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject